• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Front Immunol . Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas

tetano

Editor, Senior Moderator
Front Immunol


. 2022 Jan 31;13:823949.
doi: 10.3389/fimmu.2022.823949. eCollection 2022.
Inactivated Rabies Virus Vectored MERS-Coronavirus Vaccine Induces Protective Immunity in Mice, Camels, and Alpacas


Hang Chi[SUP] 1 [/SUP], Yanqun Wang[SUP] 2 [/SUP], Entao Li[SUP] 1 [/SUP], Xiwen Wang[SUP] 3 [/SUP], Hualei Wang[SUP] 4 [/SUP], Hongli Jin[SUP] 4 [/SUP], Qiuxue Han[SUP] 1 [/SUP], Zhenshan Wang[SUP] 1 [/SUP], Xinyue Wang[SUP] 1 [/SUP], Airu Zhu[SUP] 2 [/SUP], Jing Sun[SUP] 2 [/SUP], Zhen Zhuang[SUP] 2 [/SUP], Lu Zhang[SUP] 5 [/SUP], Jingmeiqi Ye[SUP] 6 [/SUP], Haijun Wang[SUP] 7 [/SUP], Na Feng[SUP] 1 [/SUP], Mingda Hu[SUP] 8 [/SUP], Yuwei Gao[SUP] 1 [/SUP], Jincun Zhao[SUP] 2 9 10 [/SUP], Yongkun Zhao[SUP] 1 [/SUP], Songtao Yang[SUP] 1 [/SUP], Xianzhu Xia[SUP] 1 [/SUP]



Affiliations

Abstract

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emergent coronavirus that has caused frequent zoonotic events through camel-to-human spillover. An effective camelid vaccination strategy is probably the best way to reduce human exposure risk. Here, we constructed and evaluated an inactivated rabies virus-vectored MERS-CoV vaccine in mice, camels, and alpacas. Potent antigen-specific antibody and CD8[SUP]+[/SUP] T-cell responses were generated in mice; moreover, the vaccination reduced viral replication and accelerated virus clearance in MERS-CoV-infected mice. Besides, protective antibody responses against both MERS-CoV and rabies virus were induced in camels and alpacas. Satisfyingly, the immune sera showed broad cross-neutralizing activity against the three main MERS-CoV clades. For further characterization of the antibody response induced in camelids, MERS-CoV-specific variable domains of heavy-chain-only antibody (VHHs) were isolated from immunized alpacas and showed potent prophylactic and therapeutic efficacies in the Ad5-hDPP4-transduced mouse model. These results highlight the inactivated rabies virus-vectored MERS-CoV vaccine as a promising camelid candidate vaccine.

Keywords: MERS-CoV; alpaca; camel; mice; rabies virus vector; vaccine.
 
Back
Top